Xenetic Biosciences

About:

Xenetic Biosciences is a biopharmaceutical company that provides drugs, cancer therapies, and vaccines.

Website: http://www.xeneticbio.com

Twitter/X: xeneticbio

Top Investors: Baxter International

Description:

Xenetic is a leading UK-based biopharmaceutical company providing leading-edge expertise in the development of a whole new generation of drugs, cancer therapies, and vaccines. Xenetic Biosciences is formerly known as Lipoxen. Working with some of the largest pharmaceutical organizations in the world, Xenetic provides specialist delivery solutions to improve the efficacy and performance of drugs and vaccines in a number of key medical areas including oncology.

Total Funding Amount:

$47M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Framingham, Massachusetts, United States

Founded Date:

2011-08-01

Contact Email:

info(AT)xeneticbio.com

Founders:

Gregory Gregoriadis

Number of Employees:

1-10

Last Funding Date:

2022-10-12

IPO Status:

Public

Industries:

© 2025 bioDAO.ai